Arexvy RSV Vaccine Expansion: Broader Access an...

By HEOR Staff Writer

December 15, 2025

CHMP Backs Arexvy RSV Vaccine Expansion for All Adults 18+ The Arexvy RSV vaccine expansion has received a positive recommendation from the European Medicines Agency's Commit...
Provisional Agreement on EU Pharmaceutical Reform: Boosting Innovation and Co...
AI Governance Pharmaceuticals: Ensuring Ethical AI Integration in the Medicin...
NICE Approves Seven Digital Cardiac Rehabilitation Technologies for Enhanced ...
Repurposing Off-Patent Medicines: Insights from the EU Pilot Initiative
Advancing EU Health Technology Assessment: Key Priorities in the HTACG Draft ...
WHO Guidelines Set New Standard for GLP-1 Obesity Therapies in Adults
Strengthening EU Pharmaceutical Supply Security Through the Critical Medicine...
Enhancing Efficiency in FAST-EU Clinical Trials: A New Era for Biomedical Res...
NICE Endorses Obecabtagene Autoleucel Therapy for Adult Relapsed B-Cell Leuka...
Rethinking HEOR Market Access Integration: A Call for Early Engagement Before...
Addressing AI Polyp Detection Gaps: A Roadmap for Evidence Generation and NHS...
Health Investment Returns: Harnessing Health as a Strategic Economic Asset